Manufacturers are investing in key recombinant vaccines and improving product pipelines, driving growth in the market.

Dog Vaccines Market Dog Vaccines Market Dublin, Jan. 15, 2025 (GLOBE NEWSWIRE) -- The "Dog Vaccines Market Size, Share & ...

ADVERTISEMENTAs part of its encouragement to parents to ensure their children are up to date with the Flu vaccine, the HSE is ...

Studies conducted in mice have shown that the COVID-19 vaccine being developed by researchers at the University of São Paulo's Medical School (FM-USP) in Brazil is safe and efficacious.

Preliminary U.S. BRIUMVI fourth quarter and full year 2024 net product revenue of $103.6 million and $310 million, respectively. Full Year 2025 target total global revenue of appr ...

Rising global focus on innovative oral vaccines underscores a transformative shift in immunization strategies, emphasizing ...

A new tuberculosis vaccine that self-destructs to enhance safety has shown promising results in macaque monkeys, providing ...

An article describing the results is published in the journal Scientific Reports. “Most vaccines are based on attenuated or inactivated viruses, but our next-generation strategy enables us to ...

Researchers have discovered that T cells can completely prevent viral infection, paving the way for new and more effective ...

A self-destructing vaccine administered intravenously provides additional safety and protection against tuberculosis (TB) in ...